Westwater Resources Announces Second Quarter/Six Months Conference Call
Management Will Discuss Financial Results and Present an Update on Activities at the Kellyton Graphite…
4 years ago
Netcetera AG: Into the era of innovative and sustainable cloud payment solutions
Netcetera goes cloud by migrating the 3DS Server from on-prem data centers to a cloud…
4 years ago
Medivolve Provides Update on its Mobile Clinic Network
TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF;…
4 years ago
Provident Financial Holdings Reports Fourth Quarter and Fiscal Year 2022 Results
Net Income of $2.46 Million in the June 2022 Quarter Net Income of $9.09 Million…
4 years ago
Jumio Announces Highest Sales Quarter Ever Powered by Financial Services and Healthcare Initiatives
Q2 highlights include launch of San Diego Innovation Lab, key executive hires and industry recognition…
4 years ago
2022 Database of Home Furnishings Retailers in Asia – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Database of Home Furnishings Retailers in Asia" database has been added to ResearchAndMarkets.com's…
4 years ago
The Fifth CIIE Benefits Countries Along the Belt and Road
SHANGHAI--(BUSINESS WIRE)--$CHINA #china--A major platform for international procurement, investment promotion, cultural exchanges and open cooperation,…
4 years ago
ViewQwest Continues SASE Market Expansion in SEA with new HK Point of Presence (PoP)
Expanded coverage to serve growing regional and global customer base SINGAPORE - Media OutReach -…
4 years ago
Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to Commercialize Bevacizumab Biosimilar in the US, Europe, Canada, MENA, Brazil, Mexico, South Africa, CIS and the SEA countries
SINGAPORE--(BUSINESS WIRE)--#HD204--Prestige Biopharma Limited (KRX: 950210, hereafter referred to as “Prestige”) and Intas Pharmaceuticals Limited…
4 years ago
Seagen and Astellas Announce Positive Topline Results For PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) as First-Line Treatment for Advanced Urothelial Cancer
– Companies plan to discuss results with regulatory authorities – BOTHELL, Wash. & TOKYO--(BUSINESS WIRE)--Seagen…
4 years ago